"Aminophenols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Phenols substituted in any position by an amino group.
Descriptor ID |
D000627
|
MeSH Number(s) |
D02.092.146.100 D02.455.426.559.389.657.050
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminophenols".
Below are MeSH descriptors whose meaning is more specific than "Aminophenols".
This graph shows the total number of publications written about "Aminophenols" by people in this website by year, and whether "Aminophenols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 2 | 0 | 2 |
2017 | 2 | 1 | 3 |
2018 | 2 | 2 | 4 |
2019 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminophenols" by people in Profiles.
-
Simultaneous Determination of Paracetamol, Propyphenazone and Caffeine in Presence of Paracetamol Impurities Using Dual-Mode Gradient HPLC and TLC Densitometry Methods. J Chromatogr Sci. 2021 Jan 14; 59(2):140-147.
-
Transcriptomic Responses to Ivacaftor and Prediction of Ivacaftor Clinical Responsiveness. Am J Respir Cell Mol Biol. 2019 11; 61(5):643-652.
-
Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis. Clin Chem Lab Med. 2019 Oct 25; 57(11):e274-e278.
-
Negotiations between the NHS and Vertex on access to lumacaftor and ivacaftor become protracted. Lancet Respir Med. 2019 09; 7(9):739-740.
-
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2. Eur Heart J. 2019 06 14; 40(23):1832-1836.
-
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials. J Cyst Fibros. 2019 09; 18(5):700-707.
-
Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case report. BMC Pulm Med. 2019 Apr 11; 19(1):76.
-
Combination therapy. Nat Med. 2019 01; 25(1):19.
-
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018 10 25; 379(17):1599-1611.
-
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis. Cochrane Database Syst Rev. 2018 08 02; 8:CD010966.